Although the nature of the tumor complicates identification of CD4+ T cell responses the CD8+ TCRαβ+ T cells clearly represent a responding T cell population capable of specific recognition, cytokine production and anti-MDV capability [38], [39], [63]. This evidence concerns the gene CD4 and neoplasm.